ADJUVANT-2NCT06373042
Tirofiban for Successful Endovascular Stroke Thrombectomy
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 2 versions: 2 with changes below.
- Minor Changed Registry marked status Unknown (sponsor has not verified the record since May 2024); last known: Not Yet Recruiting
- Minor Collaborators reorderedv2
- Study First Submitted
- Minor: routine updates
Endpoints
Primary
Functional independence
Timeframe: 90 days post-randomization
Secondary (12)
Recanalization on follow-up CTA or MRA
Early neurologic improvement
Level of disability
Excellent outcome
Independent ambulation
Show 7 moreShow less
Health-related quality of life
Long-term of disability level
Health-related quality of life (long-term)
Incidence of symptomatic intracranial hemorrhage (SICH)
Radiologic intracranial hemorrhage rate
Mortality
Incidence of non-hemorrhagic serious adverse events
Arms and interventions
TirofibanExperimental
Intraarterial and intravenous tirofiban
PlaceboPlacebo comparator
Intraarterial and intravenous placebo
Drugs: Intraarterial and intravenous tirofiban, Intraarterial and intravenous placebo